INSIGHTS ON CLINICAL TRIAL PARTNERING

• DCTs And Community-Based Research Execution And Compliance

  The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.

• 10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them

  Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.

• The Path Forward In Oncology Trials

  A comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.

• Expand Bandwidth With A Trusted Regulatory Writing Partner

  Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.

• The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears Fast

  8/13/2026

  Discover how to maintain strategic leverage during vendor selection. Learn to identify flexible, long-term partners who keep clinical trials on track before contracts are signed.

• Clinical Trial Budgeting Faces Pressure To Modernize

  6/26/2026

  Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.

• Go From Three Meetings To One With AI-Enabled eCOA

  5/5/2026

  Learn how to turn three meetings into one with AI that is streamlining clinical workflows by reducing redundant steps, simplifying site operations, and accelerating data collection.

• Flying On Two Wings: Balancing Local Agility And Global Quality In China

  8/12/2026

  As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.

• Consolidating Access Into A Single Platform: A Site CEO's Perspective

  2/28/2025

  By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.